![](https://cdn.physiciansweekly.com/wp-content/uploads/2024/07/image1720765805.jpg)
FDA Approves Zoryve for Atopic Dermatitis
THURSDAY, July 11, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older). Zoryve …